Two studies reported SIRT1 is over-expressed in primary CLL cells and in the JVM-3 and MEC-2 CLL cell lines and that inhibiting SIRT1 expression might activate the p53 pathway inhibiting cell proliferation and promoting apoptosis in CLL (28, 29). The gene discussed is TP53; the disease is B-cell chronic lymphocytic leukemia.